CoChat

Skin disease: a cardinal feature of systemic sclerosis

Krieg, T., Takehara, K. · 2006 · Rheumatology

The DOI matches its Crossref record; 39 of the 42 references it cites were found in a registry or an index.

Abstract

Despite the heterogeneity of SSc, almost all patients have skin involvement. As such, skin manifestations are critical in the initial diagnosis of SSc and in the subsequent sub-classification into the different subsets of disease. The two principal subsets are lcSSc and dcSSc. The main difference between these two subsets is the speed of disease progression and the extent and severity of skin and visceral involvement; lcSSc has an insidious onset with skin involvement confined largely to the face and extremities. Whilst vascular manifestations of SSc such as pulmonary arterial hypertension are typically more common in lcSSc, patients in both subsets can develop ischaemic digital ulcers. In dcSSc, disease progression is very rapid, with skin thickening extending beyond the extremities and earlier, more widespread internal organ involvement. DcSSc is generally considered to be the more severe subset of the disease. Skin scores in SSc correlate inversely with survival and are considered a valuable marker of disease severity. Skin involvement is easily detectable and, using the modified Rodnan skin score, the degree of skin fibrosis can be quantified. As well as general management measures, a number of targeted therapies are commonly used for treatment of cutaneous manifestations of SSc. These include the intravenous prostanoid iloprost and the dual endothelin receptor antagonist bosentan, which is approved in Europe for the prevention of new digital ulcers.

Overview

Integrity signals

Registry

Crossref · 10.1093/rheumatology/kep108

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 39 references

Research works printed but not linked: 7

  1. Gintrac, 1847, Note sur la sclerodermie, Rev Med Chir Paris, 2, 263
  2. Korn, 2001, Pathogenesis of systemic sclerosis, 1643
  3. Ingraham, 2006, Morbidity of digital tip ulcerations in scleroderma, Arthritis Rheum, 54, F78
  4. Poormoghim, 2000, Systemic sclerosis sine scleroderma, Arthritis Rheum, 43, 444, 10.1002/1529-0131(200002)43:2<444::aid-anr27>3.0.co;2-g · doi:10.1002/1529-0131(200002)43:2<444::aid-anr27>3.0.co;2-g
  5. Steen, 2000, Severe organ involvement in systemic sclerosis with diffuse scleroderma, Arthritis Rheum, 11, 2437, 10.1002/1529-0131(200011)43:11<2437::aid-anr10>3.0.co;2-u · doi:10.1002/1529-0131(200011)43:11<2437::aid-anr10>3.0.co;2-u
  6. Clements, 2000, Skin thickness score as a predictor and correlate of outcome in systemic sclerosis, Arthritis Rheum, 43, 2445, 10.1002/1529-0131(200011)43:11<2445::aid-anr11>3.0.co;2-q · doi:10.1002/1529-0131(200011)43:11<2445::aid-anr11>3.0.co;2-q
  7. Steen, 2001, Improvement in skin thickening in systemic sclerosis associated with improved survival, Arthritis Rheum, 44, 2828, 10.1002/1529-0131(200112)44:12<2828::aid-art470>3.0.co;2-u · doi:10.1002/1529-0131(200112)44:12<2828::aid-art470>3.0.co;2-u

Cited by

See all 167

Metadata

Authors
Krieg, T., & Takehara, K.
Affiliations
Kanazawa University (JP)
Venue
Rheumatology
Published
2006-06
Volume
48
Issue
suppl_3
Pages
iii14-iii18
ISSN
  • 1462-0324 (ISSN-L)
  • 1462-0332
OpenAlex
W2119959480
Cited by
135
References
42
Citations by year
2026: 2 · 2024: 7 · 2023: 7 · 2022: 9 · 2021: 5 · 2020: 10 · 2019: 9 · 2018: 16 · 2017: 8 · 2016: 12 · 2015: 8 · 2014: 8 · 2013: 8 · 2012: 7
FWCI
0.09
Type
journal article
Language
en
Open access
closed
Locations
  • Lara D. Veeken (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • University of Pittsburgh
  • Actelion Pharmaceuticals
Topics
  • Health Sciences › Medicine › Rheumatology › Systemic Sclerosis and Related Diseases
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Connective tissue disorders research
Keywords
systemic sclerosis, skin involvement, limited cutaneous systemic sclerosis, diffuse cutaneous systemic sclerosis, skin thickening, modified Rodnan skin score, skin score, disease severity, pulmonary arterial hypertension, iloprost, bosentan, endothelin receptor antagonists, prostanoids, cutaneous manifestations
MeSH terms
Collagen, Diagnosis, Differential, Fibrosis, Humans, Scleroderma, Systemic, Skin, Skin Ulcer, Transforming Growth Factor beta, Connective Tissue Growth Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Skin disease: a cardinal feature of systemic sclerosis. https://app.cochat.ai/papers/10.1093/rheumatology/kep108
The paper
Krieg, T., & Takehara, K. (2006). Skin disease: a cardinal feature of systemic sclerosis. Rheumatology. https://doi.org/10.1093/rheumatology/kep108

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.